Malaria vaccine trials.
Greenwood
Brian
B
Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK. brian.greenwood@lshtm.ac.uk
Alonso
Pedro
P
D000328:Adult; D000367:Age Factors; D000818:Animals; D000953:Antigens, Protozoan / Q000276:immunology; D001029:Aotus trivirgatus; D015415:Biomarkers; D002648:Child; D002986:Clinical Trials as Topic / Q000191:economics / Q000379:methods* / Q000592:standards / Q000706:statistics & numerical data; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D017326:Clinical Trials, Phase III as Topic; D017327:Clinical Trials, Phase IV as Topic; D004992:Ethics, Medical; D006801:Humans; D015994:Incidence; D015993:Life Tables; D008288:Malaria / Q000453:epidemiology / Q000517:prevention & control / Q000635:transmission; D017780:Malaria Vaccines / Q000191:economics / Q000276:immunology; D023421:Models, Animal; D010961:Plasmodium / Q000276:immunology; D015995:Prevalence; D012107:Research Design; D014195:Travel; D017778:Vaccines, Combined
D000953:Antigens, Protozoan; D015415:Biomarkers; D017780:Malaria Vaccines; D017778:Vaccines, Combined